[Treatment of fibromyalgia]

Zh Nevrol Psikhiatr Im S S Korsakova. 1998;98(4):40-3.
[Article in Russian]

Abstract

The paper reports the results of therapy of 23 patients with fibromyalgia (FM). Tetracyclic antidepressant lerivon, was administered to group 1, nonsteroid antiinflammatory (NSAI) preparation nurofen to group 2 and phototherapy (exposure to bright white light) was used in group 3. Clinical effect in the form of a decrease of both the intensivity of algesic syndrome and autonomic manifestations as well as improvement of night sleep were clearly seen in group 1. Manifestations of both anxious and depressive disorders were less pronounced. Treatment by Nurofen resulted in slight decrease of intensivity of pains but didn't lead to pronounced alterations of emotional sphere. Administration of either Lerivon or Nurofen promoted the increase of pain thresholds (according to the data of nociceptive flexory reflex). The data obtained testified the necessity of complex therapy of FM patients including administration of antidepressants and analgetic drugs of NSAI group. Dynamic polysomnographic examination of patients from group 3 revealed the increase of total sleep duration, decrease of the time of falling asleep, the latent period of the phase of the fast sleep, activated movement index, intensivity of movements and the time of being awake in the sleep. The conclusion was made that it was worth while to use phototherapy as alternative, nonmedicine method of phothotherapy.

Publication types

  • Comparative Study
  • English Abstract

MeSH terms

  • Adult
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
  • Antidepressive Agents, Second-Generation / therapeutic use*
  • Anxiety Disorders / complications
  • Anxiety Disorders / diagnosis
  • Anxiety Disorders / therapy
  • Depression / complications
  • Depression / diagnosis
  • Depression / therapy
  • Diagnosis, Differential
  • Drug Therapy, Combination
  • Female
  • Fibromyalgia / complications
  • Fibromyalgia / diagnosis
  • Fibromyalgia / therapy*
  • Humans
  • Male
  • Mianserin / therapeutic use*
  • Middle Aged
  • Phototherapy*
  • Polysomnography
  • Treatment Outcome

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Antidepressive Agents, Second-Generation
  • Mianserin